Date: October 13, 2026

Disinvestment / Strategic Actions

PathLabs Unifiers Private Limited (PUPL), a wholly owned subsidiary of Dr. Lal PathLabs Limited, has acquired the remaining 30% equity stake in Centrapath Labs Private Limited (CPL) on October 13, 2026.

Acquisition Details:

  • Target Entity: Centrapath Labs Private Limited (CPL)
  • Acquisition Percentage: 30% equity stake
  • Total Ownership Post-Acquisition: CPL becomes a wholly owned subsidiary of PUPL
  • Consideration Type: Cash
  • Price per Share: INR 1608.352
  • Transaction Status: Completed

Target Company Background:

  • Incorporation Date: July 23, 2019
  • Location: Indore, Madhya Pradesh
  • Industry: Healthcare/ Diagnostics Services
  • Financial Turnover:
  • FY 2026: INR 20.5 Crores
  • FY 2025: INR 23.7 Crores
  • FY 2024: INR 20.8 Crores

Regulatory and Transaction Aspects:

  • Not a related party transaction
  • No governmental or regulatory approvals required
  • Transaction executed at arm's length

Other Operational / Legal / Strategic Disclosures

The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

KMP / Board / Auditor Changes

Not Specified

Dividend Declaration or Non-Declaration

Not Specified

Board Meeting Outcomes

Not Specified

Financial Results

Not Specified